Lisinopril/hydrochlorothiazide: Difference between revisions

Revision as of 15:22, 10 September 2011 editAnypodetos (talk \| contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 edits Undid revision 449546066 by PotatoBot (talk)← Previous edit		Revision as of 15:22, 10 September 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID\|Chem/DrNext edit →
Line 1:		Line 1:
	{{Drugbox		{{Drugbox
	\| verifiedrevid = ~~437098836~~		\| verifiedrevid = 447439314

	<!--Combo data-->		<!--Combo data-->

Revision as of 15:22, 10 September 2011

Pharmaceutical compound

Lisinopril/hydrochlorothiazide
Combination of
Lisinopril	ACE inhibitor
Hydrochlorothiazide	Thiazide diuretic
Clinical data
MedlinePlus	a601070
Routes of administration	Oral
ATC code	C09BA03 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
(verify)

Lisinopril/hydrochlorothiazide (trade name Prinzide by Merck & Co., Zestoretic by AstraZeneca, and many others) is a combination of the drugs lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic. It is used to control hypertension.

v t e Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril (+nebivolol) Dicarboxylate-containing: Enalapril (+lercanidipine, +nitrendipine) Benazepril (+amlodipine, +pimobendan) Cilazapril Delapril (+manidipine) Imidapril Lisinopril (+amlodipine, +HCT) Moexipril Perindopril (+amlodipine, +bisoprolol, +indapamide, +amlodipine and indapamide, +bisoprolol and amlodipine, +bisoprolol, amlodipine, and indapamide) Quinapril (+HCT) Ramipril (+amlodipine, +amlodipine and HCT, +bisoprolol, +felodipine) Spirapril Temocapril Trandolapril (+verapamil) Phosphonate-containing: Ceronapril Fosinopril (+HCT) Other/ungrouped: Alacepril
AIIRAs ("-sartan")	Azilsartan Candesartan (+amlodipine, +amlodipine and HCT) Eprosartan Fimasartan Irbesartan (+amlodipine, +amlodipine and HCT, +HCT) Losartan (+amlodipine, +HCT) Olmesartan (+amlodipine, +amlodipine and HCT, +HCT) Tasosartan Telmisartan (+amlodipine, +amlodipine and HCT, +HCT) Valsartan (+aliskiren, +amlodipine, +amlodipine and HCT, +HCT, +lercanidipine, +nebivolol, +sacubitril)
Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +HCT, +amlodipine and HCT) Remikiren
Dual ACE/NEP inhibitors	Gemopatrilat Ilepatril Omapatrilat Sampatrilat
Neprilysin inhibitors	Sacubitril (+valsartan)
Other	Sparsentan
WHO-EM Withdrawn from market Clinical trials: Phase III Never to phase III

This antihypertensive-related article is a stub. You can help Misplaced Pages by expanding it.